FDA orders new warning on GLP-1 weight loss drugs
FDA orders new warning on GLP-1 weight loss drugs

FDA orders new warning on GLP-1 weight loss drugs

All GLP-1 drugs, which include popular brands like Ozempic and Wegovy, will soon carry new labels warning people taking the medications about a possible side effect that could lead to permanent vision loss. Dr. Bradley Katz with University of Utah Health joins LiveNOW's Andy Mac to discuss.

Latest LiveNOW Stories

From the Archives

Consumer & Money

Science & Tech

Police Chases

Weather Across the Country